<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="TAB2" orientation="portrait" position="float">
 <label>Table 2</label>
 <caption>
  <title>Randomized control trials of combination drugs</title>
  <p>*Due to the vast number of ongoing trials, trials in this chart are limited to those with &gt;1000 participants</p>
  <p>NCT ID: National Clinical Trial Identifier; SARS-CoV-2: severe acute respiratory syndrome coronavirus 2</p>
 </caption>
 <table frame="hsides" rules="groups">
  <colgroup span="1">
   <col span="1"/>
   <col span="1"/>
   <col span="1"/>
   <col span="1"/>
   <col span="1"/>
  </colgroup>
  <tbody>
   <tr style="background-color:#ccc">
    <td rowspan="1" colspan="1">Intervention</td>
    <td rowspan="1" colspan="1">NCT ID</td>
    <td rowspan="1" colspan="1">No. of participants*</td>
    <td rowspan="1" colspan="1">Duration</td>
    <td rowspan="1" colspan="1">Phase</td>
    <td rowspan="1" colspan="1">Sponsor</td>
   </tr>
   <tr>
    <td colspan="6" rowspan="1">Combination drugs</td>
   </tr>
   <tr style="background-color:#ccc">
    <td rowspan="1" colspan="1">Drug: hydroxychloroquine + intravenous famotidine</td>
    <td rowspan="1" colspan="1">NCT04370262</td>
    <td rowspan="1" colspan="1">1170</td>
    <td rowspan="1" colspan="1">April 2020– April 2021</td>
    <td rowspan="1" colspan="1">Phase 3</td>
    <td rowspan="1" colspan="1">Northwell Health</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Drug: thiazide or thiazide-like diuretics; drug: calcium channel blockers; drug: ACE inhibitor; drug: angiotensin receptor blocker</td>
    <td rowspan="1" colspan="1">NCT04330300</td>
    <td rowspan="1" colspan="1">2414</td>
    <td rowspan="1" colspan="1">March 2020– March 2021</td>
    <td rowspan="1" colspan="1">Phase 4</td>
    <td rowspan="1" colspan="1">National University of Ireland, Galway, Ireland</td>
   </tr>
   <tr style="background-color:#ccc">
    <td rowspan="1" colspan="1">Drug: lopinavir/ritonavir; drug: hydroxychloroquine sulfate; drug: losartan; drug: placebos</td>
    <td rowspan="1" colspan="1">NCT04328012</td>
    <td rowspan="1" colspan="1">4000</td>
    <td rowspan="1" colspan="1">April 2020–April 2021</td>
    <td rowspan="1" colspan="1">Phase 2, phase 3</td>
    <td rowspan="1" colspan="1">Bassett Healthcare</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Drug: remdesivir; drug: lopinavir/ritonavir; drug: interferon beta-1A; drug: hydroxychloroquine; other: standard of care</td>
    <td rowspan="1" colspan="1">NCT04315948</td>
    <td rowspan="1" colspan="1">3100</td>
    <td rowspan="1" colspan="1">March 2020–March 2023</td>
    <td rowspan="1" colspan="1">Phase 3</td>
    <td rowspan="1" colspan="1">Institut National de la Santé Et de la Recherche Médicale, France</td>
   </tr>
   <tr style="background-color:#ccc">
    <td rowspan="1" colspan="1">Drug: lopinavir/ritonavir; drug: hydroxychloroquine; drug: remdesivir</td>
    <td rowspan="1" colspan="1">NCT04330690</td>
    <td rowspan="1" colspan="1">2900</td>
    <td rowspan="1" colspan="1">March 2020–May 2022</td>
    <td rowspan="1" colspan="1">Phase 2</td>
    <td rowspan="1" colspan="1">Sunnybrook Health Sciences Centre</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Biological: convalescent anti-SARS-CoV-2 plasma; drug: sarilumab; drug: baricitinib; drug: hydroxychloroquine; other: injective placebo; other: oral placebo</td>
    <td rowspan="1" colspan="1">NCT04345289</td>
    <td rowspan="1" colspan="1">1500</td>
    <td rowspan="1" colspan="1">May 2020–June 2021</td>
    <td rowspan="1" colspan="1">Phase 3</td>
    <td rowspan="1" colspan="1">Thomas Benfield</td>
   </tr>
   <tr style="background-color:#ccc">
    <td rowspan="1" colspan="1">Drug: lopinavir-ritonavir; drug: corticosteroid; drug: hydroxychloroquine; drug: azithromycin; biological: convalescent plasma; drug: tocilizumab</td>
    <td rowspan="1" colspan="1">NCT04381936</td>
    <td rowspan="1" colspan="1">12000</td>
    <td rowspan="1" colspan="1">March 2020–June 2021</td>
    <td rowspan="1" colspan="1">Phase 2, phase 3</td>
    <td rowspan="1" colspan="1">University of Oxford</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Drug: hydroxychloroquine sulfate tablets; drug: lopinavir/ritonavir oral tablet; drug: hydroxychloroquine sulfate tablets plus lopinavir/ritonavir oral tablets; drug: placebo</td>
    <td rowspan="1" colspan="1">NCT04403100</td>
    <td rowspan="1" colspan="1">1968</td>
    <td rowspan="1" colspan="1">June 2020–November 2020</td>
    <td rowspan="1" colspan="1">Phase 3</td>
    <td rowspan="1" colspan="1">Cardresearch</td>
   </tr>
   <tr style="background-color:#ccc">
    <td rowspan="1" colspan="1">Drug: hydroxychloroquine; drug: azithromycin</td>
    <td rowspan="1" colspan="1">NCT04334382</td>
    <td rowspan="1" colspan="1">1550</td>
    <td rowspan="1" colspan="1">April 2020–December 2021</td>
    <td rowspan="1" colspan="1">Phase 3</td>
    <td rowspan="1" colspan="1">Intermountain Health Care, Inc.</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Drug: hydroxychloroquine; drug: azithromycin (Azithro); drug: placebo for hydroxychloroquine; drug: placebo for azithromycin</td>
    <td rowspan="1" colspan="1">NCT04358068</td>
    <td rowspan="1" colspan="1">2000</td>
    <td rowspan="1" colspan="1">May 2020–March 2021</td>
    <td rowspan="1" colspan="1">Phase 2</td>
    <td rowspan="1" colspan="1">National Institute of Allergy and Infectious Diseases (NIAID)</td>
   </tr>
   <tr style="background-color:#ccc">
    <td rowspan="1" colspan="1">Drug: hydroxychloroquine; drug: placebo oral tablet</td>
    <td rowspan="1" colspan="1">NCT04318444</td>
    <td rowspan="1" colspan="1">1600</td>
    <td rowspan="1" colspan="1">March 2020–March 2022</td>
    <td rowspan="1" colspan="1">Phase 2, phase 3</td>
    <td rowspan="1" colspan="1">Columbia University</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Drug: favipiravir (3200 mg + 1200 mg); drug: favipiravir (3600 mg + 1600 mg); drug: favipiravir (3200 mg + 1200 mg) combined with hydroxychloroquine; drug: favipiravir (3200 mg + 1200 mg) combined with azithromycin; drug: hydroxychloroquine; drug: hydroxychloroquine combined with azithromycin</td>
    <td rowspan="1" colspan="1">NCT04411433</td>
    <td rowspan="1" colspan="1">1000</td>
    <td rowspan="1" colspan="1">May 2020–July 2020</td>
    <td rowspan="1" colspan="1">Phase 3</td>
    <td rowspan="1" colspan="1">Ministry of Health, Turkey</td>
   </tr>
   <tr style="background-color:#ccc">
    <td rowspan="1" colspan="1">Drug: hydroxychloroquine - daily dosing; drug: hydroxychloroquine - weekly dosing</td>
    <td rowspan="1" colspan="1">NCT04341441</td>
    <td rowspan="1" colspan="1">3000</td>
    <td rowspan="1" colspan="1">April 2020–April 2021</td>
    <td rowspan="1" colspan="1">Phase 3</td>
    <td rowspan="1" colspan="1">Henry Ford Health System</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Drug: hydroxychloroquine</td>
    <td rowspan="1" colspan="1">NCT04363827</td>
    <td rowspan="1" colspan="1">2300</td>
    <td rowspan="1" colspan="1">May 2020–March 2021</td>
    <td rowspan="1" colspan="1">Phase 2</td>
    <td rowspan="1" colspan="1">Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori</td>
   </tr>
   <tr style="background-color:#ccc">
    <td rowspan="1" colspan="1">Drug: hydroxychloroquine sulfate; drug: ascorbic acid</td>
    <td rowspan="1" colspan="1">NCT04328961</td>
    <td rowspan="1" colspan="1">2000</td>
    <td rowspan="1" colspan="1">March 2020–October 2020</td>
    <td rowspan="1" colspan="1">Phase 2, phase 3</td>
    <td rowspan="1" colspan="1">University of Washington</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Drug: hydroxychloroquine; drug: placebo oral tablet</td>
    <td rowspan="1" colspan="1">NCT04334148</td>
    <td rowspan="1" colspan="1">15000</td>
    <td rowspan="1" colspan="1">April 2020–July 2020</td>
    <td rowspan="1" colspan="1">Phase 3</td>
    <td rowspan="1" colspan="1">Adrian Hernandez</td>
   </tr>
   <tr style="background-color:#ccc">
    <td rowspan="1" colspan="1">Drug: emtricitabine/tenofovir disoproxil; drug: hydroxychloroquine; drug: placebo: emtricitabine/tenofovir disoproxil placebo; drug: placebo: hydroxychloroquine</td>
    <td rowspan="1" colspan="1">NCT04334928</td>
    <td rowspan="1" colspan="1">4000</td>
    <td rowspan="1" colspan="1">April 2020–July 2020</td>
    <td rowspan="1" colspan="1">Phase 3</td>
    <td rowspan="1" colspan="1">Plan Nacional sobre el Sida (PNS)</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Drug: hydroxychloroquine; drug: placebo</td>
    <td rowspan="1" colspan="1">NCT04325893</td>
    <td rowspan="1" colspan="1">1300</td>
    <td rowspan="1" colspan="1">April 2020–September 2020</td>
    <td rowspan="1" colspan="1">Phase 3</td>
    <td rowspan="1" colspan="1">University Hospital, Angers</td>
   </tr>
   <tr style="background-color:#ccc">
    <td rowspan="1" colspan="1">Drug: hydroxychloroquine; drug: placebo oral tablet</td>
    <td rowspan="1" colspan="1">NCT04421664</td>
    <td rowspan="1" colspan="1">1500</td>
    <td rowspan="1" colspan="1">March 2020–August 2020</td>
    <td rowspan="1" colspan="1">Phase 3</td>
    <td rowspan="1" colspan="1">McGill University Health Centre/Research Institute of the McGill University Health Centre</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Dietary supplement: vitamins; drug: hydroxychloroquine; drug: imatinib; drug: favipiravir; drug: telmisartan</td>
    <td rowspan="1" colspan="1">NCT04356495</td>
    <td rowspan="1" colspan="1">1057</td>
    <td rowspan="1" colspan="1">July 2020–January 2021</td>
    <td rowspan="1" colspan="1">Phase 3</td>
    <td rowspan="1" colspan="1">University Hospital, Bordeaux</td>
   </tr>
   <tr style="background-color:#ccc">
    <td rowspan="1" colspan="1">Drug: hydroxychloroquine; other: placebo</td>
    <td rowspan="1" colspan="1">NCT04308668</td>
    <td rowspan="1" colspan="1">3000</td>
    <td rowspan="1" colspan="1">March 2020–May 2020</td>
    <td rowspan="1" colspan="1">Phase 3</td>
    <td rowspan="1" colspan="1">University of Minnesota</td>
   </tr>
   <tr>
    <td rowspan="1" colspan="1">Other: placebo; drug: remdesivir; drug: baricitinib</td>
    <td rowspan="1" colspan="1">NCT04401579</td>
    <td rowspan="1" colspan="1">1032</td>
    <td rowspan="1" colspan="1">May 2020–August 2023</td>
    <td rowspan="1" colspan="1">Phase 3</td>
    <td rowspan="1" colspan="1">National Institute of Allergy and Infectious Diseases (NIAID)</td>
   </tr>
  </tbody>
 </table>
</table-wrap>
